Related Experiment Video
Updated: Sep 20, 2025
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Secretion management devices reduce hospitalizations for respiratory exacerbations in children with neurodisability
Jérôme Pradon1, Audrey Barzic2, Marc Lubrano Lavadera3
1Pediatric Pulmonology Department, Armand Trousseau Hospital, AP-HP Sorbonne University, F-75012, Paris, France.
Insights
Secretion management devices significantly reduce hospitalizations for respiratory issues in children with neurodisability. This intervention helps decrease the length of stays for pulmonary exacerbations, improving patient outcomes.
Area of Science:
- Pediatric Pulmonology
- Neurodisability Research
- Medical Device Efficacy
Background:
- Respiratory complications are a major cause of illness and death in children with neurodisability.
- Frequent pulmonary infections lead to numerous hospital admissions.
- Limited studies exist on the impact of secretion management in this vulnerable population.
Purpose of the Study:
- To evaluate the effectiveness of secretion management devices.
- To assess the impact on hospitalization duration for respiratory exacerbations.
- To analyze outcomes in children with neurodisability.
Main Methods:
- Retrospective observational multicenter study.
- Inclusion of children from four French reference centers.
- Analysis of data one year post-initiation of a secretion management device.
Main Results:
- Twenty-three children (median age 10.7 years) were included.
- Hospitalization days for pulmonary exacerbations decreased significantly from a median of 12 to 0 days (p=0.018).
- Devices included intrapulmonary percussive ventilation (IPV), intermittent positive pressure breathing (IPPB), and mechanical insufflation-exsufflation (MI-E).
Conclusions:
- Secretion management significantly reduces hospitalization duration for respiratory exacerbations in children with neurodisability.
- This multicenter study supports the use of these devices.
- Improved management of respiratory secretions is crucial for this patient group.
Background:
Respiratory complications are the leading cause of morbidity and mortality in children with neurodisability. Repeated pulmonary infections lead to multiple hospitalizations. Effective secretion management is crucial in this population, but studies on their impact are limited. This study evaluates the effect of secretion management on the duration of hospitalizations for respiratory exacerbations in children with neurodisability.
Methods:
This retrospective observational multicenter study included children from four French reference centers, between February and May 2024, one year after initiating a secretion management device.
Results:
Twenty-three patients (9 girls) with a median age of 10.7 [8.7; 15.3] years were included. Sixteen children had recurrent chest infections before initiating a secretion management device. Intrapulmonary percussive ventilation (IPV), intermittent positive pressure breathing (IPPB), and mechanical insufflation-exsufflation (MI-E) devices were prescribed to 12, 7, and 5 children, respectively. The primary indication was repeated respiratory infections in 11 children, and thoracic mobilization in 8 children. One year after device initiation, the number of days of hospitalization for pulmonary exacerbation significantly decreased from a median (range) of 12 (0-88) to 0 (0-34) days (p = 0.018).
Conclusion:
This multicenter study demonstrates that secretion management significantly reduces the duration of hospitalizations for respiratory exacerbations in children with neurodisability.
Related Concept Videos
01:23Inhaled Medications
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:29Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:16Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...